SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Sgrignari Michael (Last) (First) (Middle) C/O COVIDIEN 15 HAMPSHIRE STREET (Street) MANSFIELD MA 02048 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 07/01/2011	3. Issuer Name and Ticker or Trading Symbol Covidien plc [ COV ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Senior Vice President	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Ordinary Shares	11,107(1)	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	(2)	11/30/2018	Ordinary Shares	12,623	$34.15	D
Stock Option (Right to Buy)	(3)	11/21/2015	Ordinary Shares	7,435	$36.9903	D
Stock Option (Right to Buy)	(3)	11/21/2016	Ordinary Shares	14,111	$38.6485	D
Stock Option (Right to Buy)	(4)	11/30/2020	Ordinary Shares	20,850	$42.94	D
Stock Option (Right to Buy)	(5)	07/01/2017	Ordinary Shares	32,000	$43.0878	D
Stock Option (Right to Buy)	(3)	03/09/2015	Ordinary Shares	7,839	$45.6575	D
Stock Option (Right to Buy)	(6)	11/30/2019	Ordinary Shares	19,215	$47.6	D

Explanation of Responses:

1. Includes 8,617 restricted stock units (RSUs) and associated dividend equivalent units which generally vest in equal installments on the first, second, third and fourth anniversary of the RSU grant date and are settled in ordinary shares upon vesting.

2. These options become exercisable in equal installments on each of the third and fourth anniversary of the grant date, December 1, 2008.

3. These options are fully exercisable.

4. These options become exercisable in equal installments on each of the first, second, third and fourth anniversary of the grant date, December 1, 2010.

5. These options become fully exercisable on July 2, 2011.

6. These options become exercisable in equal installments on each of the second, third and fourth anniversary of the grant date, December 1, 2009.

Remarks:

sgrignaripoa.txt

	By: John W. Kapples, Attorney in Fact	07/01/2011
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.